Showing results (1691-1700 of 1,873) with videos related to

Sort By:
Pageof 188
Antimicrobial Agents and Chemotherapy|May 7, 2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional networkDavid van Duin, Federico Perez, Susan D Rudin, et al.
Communications Biology|November 17, 2022
Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate effluxDino Luethi, Julian Maier, Deborah Rudin, et al.
European Journal of Pediatrics|July 5, 2020
Swiss consensus recommendations on urinary tract infections in childrenMichael Buettcher, Johannes Trueck, Anita Niederer-Loher, et al.
The New England Journal of Medicine|June 8, 2012
Efficacy and safety of vismodegib in advanced basal-cell carcinomaAleksandar Sekulic, Michael R Migden, Anthony E Oro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2023
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung CancerCharles M Rudin, Stephen V Liu, Ross A Soo, et al.
Plos One|October 14, 2021
J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?Naufal Shamilevich Zagidullin, Lukas J Motloch, Timur Ilgamovich Musin, et al.
Urology|August 30, 2014
Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris)Stanislav Kocherov, Ibrahim Ulman, Sergey Nikolaev, et al.
AIDS (London, England)|April 14, 2010
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children, K Boyd, David T Dunn, et al.
Gastroenterology|May 6, 2018
Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal CancerThomas N Y Kwong, Xiansong Wang, Geicho Nakatsu, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort studyArielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, et al.
Pageof 188